Antitumor activity of brentuximab vedotin in CD30 positive refractory germ cell tumors.
Year: 2013
Type: conference-abstract
Source: Journal of Clinical Oncology
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2249738965
